Thermo Fisher Scientific | TMO - Net Income


Thermo Fisher Scientific reported $1.65B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Henry Schein USD 107M 6M Mar/2026
Illumina USD 134M 200M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Olympus JPY 24.82B 10.65B Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Stryker USD 745M 104M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Veracyte USD 28.71M 12.44M Mar/2026
Waters USD -72M 297.21M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026